blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1703797

EP1703797 - TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-[kappa]B ACTIVITY AND USE THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.02.2015
Database last updated on 07.10.2024
Most recent event   Tooltip27.02.2015Application deemed to be withdrawnpublished on 01.04.2015  [2015/14]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [2006/39]For all designated states
Bristol-Myers Squibb Company
P.O. Box 4000, Route 206 and Province Line Road
Princeton, NJ 08543-4000 / US
Inventor(s)01 / WEINSTEIN, David, S.
10 Iverness Lane
East Windsor, NJ 08520 / US
02 / YANG, Bingwei Vera
15 Regents Court
Belle Mead, NJ 08502 / US
03 / KIM, Soong-Hoon
3 Lupine Lane
Titusville, NJ 08560 / US
04 / VACCARO, Wayne
1706 Westover Road
Yardley, PA 19067 / US
05 / SHEPPECK, James
356 Crittenden Dr.
Newton, PA 18940 / US
06 / GILMORE, John
815 Hudson Dr.
Yardley, PA 19067 / US
 [2006/39]
Representative(s)Beacham, Annabel Rose, et al
Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [2010/41]Beacham, Annabel Rose, et al
Dehns St Bride's House 10 Salisbury Square London
EC4Y 8JD / GB
Former [2008/45]Howard, Paul Nicholas, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Former [2006/39]Howard, Paul Nicholas, et al
Carpmaels & Ransford, 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date05705688.914.01.2005
[2006/39]
WO2005US01180
Priority number, dateUS20040537469P16.01.2004         Original published format: US 537469 P
US2005003517613.01.2005         Original published format: US 35176
[2006/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005072132
Date:11.08.2005
Language:EN
[2005/32]
Type: A2 Application without search report 
No.:EP1703797
Date:27.09.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 11.08.2005 takes the place of the publication of the European patent application.
[2006/39]
Search report(s)International search report - published on:US02.03.2006
(Supplementary) European search report - dispatched on:EP11.12.2008
ClassificationIPC:C07C233/58, C07D277/46, C07D417/12, C07D453/06, C07D405/12, A23K1/165, A23K1/18, C07D233/88
[2013/18]
CPC:
C07D417/12 (EP,US); A23K20/168 (US); A23K50/40 (EP,US);
A61K45/06 (EP); A61P1/00 (EP); A61P11/00 (EP);
A61P17/00 (EP); A61P19/00 (EP); A61P27/02 (EP);
A61P3/00 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P5/00 (EP); C07D233/88 (EP,US); C07D277/46 (EP,US);
C07D405/12 (EP,US); C07D453/06 (EP,US) (-)
Former IPC [2008/03]C07C233/58
Former IPC [2006/39]A21D2/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/39]
Extension statesALNot yet paid
BANot yet paid
HR03.08.2006
LV03.08.2006
MK03.08.2006
YU03.08.2006
TitleGerman:TRICYCLISCHE MODULATOREN DER GLUCOCORTICOIDREZEPTOR AP-1 UND/ODER NF-KAPPA-B-AKTIVITÄT UND IHRE VERWENDUNG[2006/39]
English:TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-[kappa]B ACTIVITY AND USE THEREOF[2006/39]
French:MODULATEURS TRICYCLIQUES DU RECEPTEUR GLUCOCORTICOIDE AP-1, ET/OU DE L'ACTIVITE DE NF-_G(K)B, ET LEUR UTILISATION[2006/39]
Entry into regional phase03.08.2006National basic fee paid 
03.08.2006Search fee paid 
03.08.2006Designation fee(s) paid 
03.08.2006Examination fee paid 
Examination procedure03.08.2006Examination requested  [2006/39]
07.08.2006Amendment by applicant (claims and/or description)
10.11.2010Despatch of a communication from the examining division (Time limit: M04)
14.03.2011Reply to a communication from the examining division
24.03.2011Despatch of a communication from the examining division (Time limit: M06)
04.08.2011Reply to a communication from the examining division
25.11.2013Communication of intention to grant the patent
11.12.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
20.02.2014Communication of intention to grant the patent
27.03.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
26.05.2014Communication of intention to grant the patent
07.10.2014Application deemed to be withdrawn, date of legal effect  [2015/14]
11.11.2014Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/14]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.11.2010
Fees paidRenewal fee
03.08.2006Renewal fee patent year 03
14.01.2008Renewal fee patent year 04
14.01.2009Renewal fee patent year 05
13.01.2010Renewal fee patent year 06
14.01.2011Renewal fee patent year 07
11.01.2012Renewal fee patent year 08
10.01.2013Renewal fee patent year 09
21.01.2014Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9915493  (ROCHE DIAGNOSTICS GMBH [DE], et al) [A] 1,21 * page 2, line 29 - page 3, line 6; example 9; claims 1,3 *;
 [A]WO03007949  (MERCK & CO INC [US], et al) [A] 1,21 * claims 1,17 *;
 [PA]WO2004009017  (BRISTOL MYERS SQUIBB CO [US], et al) [PA] 1,21 * claims 1-22 *;
 [E]WO2005073221  (BRISTOL MYERS SQUIBB CO [US], et al) [E] 1* page 72, step 2*
International search[Y]US3317387  (PRICHARD WILLIAM W);
 [X]  - BUTLER DN ET AL, CANADIAN JOURNAL OF CHEMISTRY., (1972), vol. 50, pages 795 - 802, XP008112591

DOI:   http://dx.doi.org/10.1139/v72-124
ExaminationWO0066522
by applicantUS5202486
 US5447954
 US5595872
 EP0818448
 US5712279
 US5739135
 US5760246
 US5827875
 US5885983
 US5962440
 WO0038722
 WO0066522
 WO02051851
 WO2004009017
    - BALDWIN, AS, JOURNAL OF CLIN. INVESTIGATION, (2001), vol. 107, page 3
    - FIRESTEIN, G.S., MANNING, A.M., ARTHRITIS AND RHEUMATISM, (1999), vol. 42, page 609
    - PELTZ, G., CURR. OPIN, IN BIOTECH., (1997), vol. 8, page 467
    - TUCKERMANN, J. ET AL., CELL, (1998), vol. 93, page 531
    - REICHARDT, HM, EMBO J., (2001), vol. 20, page 7168
    - JACKSON ET AL., BIOORG. MED. CHEM., (2002), vol. 12, pages 1093 - 1097
    - FUKUMI ET AL., HETEROCYCLES, (1978), vol. 9, no. 9, pages 1197 - 1205
    - SIMCHEN ET AL., JUSTUS LIEBIGS ANN. CHEM., (1974), pages 1802 - 1812
    - PLIENINGER ET AL., CHEM. BER., (1964), vol. 97, pages 667 - 681
    - MIRAK ET AL., TET. LETT., (1970), pages 1209 - 1212
    - LASZLO ET AL., HUNG. ACTA CHIM. HUNGARICA, (1985), vol. 120, no. 4, pages 271 - 274
    - NAZAKI ET AL., BULL. CHEM. SOC. JAP., (1975), vol. 48, no. 11, pages 3278 - 3284
    - BARRISH ET AL., BIOMED. CHEM., (1993), vol. 1, no. 4, pages 309 - 325
    - PETRZILKA, "Preparation and Diels-Alder Reactions of Hetero-Substituted 1,3-Dienes", SYNTHESIS, (1981), pages 753 - 786
    - SUNDBERG ET AL., J. ORG. CHEM., (1981), vol. 46, page 4836
    - FOWLER, F., J. ORG. CHEM., (1972), vol. 37, no. 9, pages 1321 - 1323
    - DRUGS OF THE FUTURE, (1999), vol. 24, pages 425 - 430
 US19980175180
 US20020396907
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.